Donald J. Hayden, Jr.
@donaldjhaydenjr
Director
Building REGENXBIO Inc. as Director
- Website not added yet
- LinkedIn not added yet
- X not added yet
- Instagram not added yet
- Facebook not added yet
Founder Rating
1500
Everyone starts at 1500.
It only moves when two founders agree to a duel.
In context
Dimension Therapeutics, Inc. was founded in 2013 and has no closure on record.
Named alongside
- Bradley CampbellPresident and Chief Executive Officer of the Issuer
- Bradley L. CampbellPresident and Chief Operating Officer of the Issuer
- Burke W WhitmanDirector
- Burke W. WhitmanDirector
- Craig A WheelerDirector
- Craig A. WheelerDirector
- Daphne D. QuimiExecutive Officer
- Daphne L. QuimiChief Financial Officer of the Issuer
At Dimension Therapeutics, Inc.
- Allan J. FoxDirector
- Annalisa JenkinsExecutive Officer, Director
- Benjamin AuspitzDirector
- Benjamin J. AuspitzDirector
- Donald J. HaydenDirector
- Jay K. HachigianExecutive Officer
- RISHI GUPTADirector
- Anupam J. DalalDirector
- Anupam K. DalalDirector
- Chen K. YuDirector
- David K. SchnellDirector
- Dennis K. FentonDirector
- Donald K. Hayden, Jr.Director
- Jeffrey K. TongExecutive Officer, Director
- Joseph L. Turner, Jr.Director
- Allan M. FoxDirector
- Benjamin T. AuspitzDirector
- Camille J. SamuelsDirector
- John Daniel KiserDirector
- Kenneth T. MillsExecutive Officer, Director
- Luke J. BesharDirector
- Allan FoxDirector
- Anna J. FrenchDirector
- Brian DoveyDirector
- Brian HalakExecutive Officer, Director
- Brian J. DoveyDirector
- Daniel J. O'DonnellDirector
Contribution
Donald's ideas, decisions and failures appear here once this profile is claimed.
Companies
- REGENXBIO Inc.Biological Products, (No Diagnostic Substances); formerly ReGenX Biosciences, LLC; listed on Nasdaq as RGNX; filing with the SEC since 2013Director · Biotechnology · WASHINGTON, United States
- Nora Therapeutics, Inc.Director · Biotechnology · PALO ALTO, United States
- Dimension Therapeutics, Inc.Biological Products, (No Diagnostic Substances); filing with the SEC since 2013Director · Biological Products, (No Diagnostic Substances) · CAMBRIDGE, United States · Founded 2013
- AMICUS THERAPEUTICS INCPharmaceutical Preparations; formerly AMICUS THERAPEUTICS INC; filing with the SEC since 2017Director · Biotechnology · Cranbury, United States
- WindMIL Therapeutics, Inc.Executive Officer, Director · Biotechnology · PRINCETON, United States · Founded 2015